Skip to main content
. 2023 Mar 31;14:1112865. doi: 10.3389/fneur.2023.1112865

Table 1.

Study demographics.

Control (n = 49) SCD (n = 88) p a
Black race, n (percent) 49 (100.0%) 86 (97.73%) 0.54c
Male sex, n (percent) 21 (42.86%) 43 (48.86%) 0.25
Hemoglobin genotype 49 HbAA 100%) 80 HbSS (91%) 8 HbSB0 (9%) n/a
Age at MRI, years, median (IQR) 23.75 (12.83) 18.06 (15.42) 0.26d
SCI present, n (percent) n/a 31 (35.23%) n/a
SCI counte, median (IQR) n/a 4 (5) n/a
Total SCI burdene, mL, median (IQR) n/a 0.14 (0.33) n/a
Gray matter volume, mean (SD) 619.40 (74.16) 626.21 (67.99) 0.588
White matter volume, mean (SD) 441.31 (55.17) 435.62 (62.52) 0.595
GM CBF, ml/100 g/min, mean (SD) 50.64 (8.9) 82.47 (17.92) <0.001
WM CBF, ml/100 g/min, mean (SD) 24.99 (4.16) 40.49 (10.81) <0.001
Regular blood transfusions, n (percent) n/a 0 (0.0%) n/a
CaO2, mL/dL, mean (SD) 17.38 (2.12) 11.63 (1.85) <0.001
SaO2, percent, median (IQR) 98.0 (2.0) 96.0 (3.26) <0.001d
Hemoglobin, g/dL, mean (SD) 13.28 (1.57) 9.04 (1.37) <0.001
Hemoglobin S fraction, percent, median (IQR) n/a 0.77 (0.16) n/a
Intracranial stenosis > 70%, n, (percent) 0 (0.0%) 0 (0.0%) n/a
Hydroxyurea therapy, n (percent) n/a 79 (89.77%) n/a
Type 1 diabetes mellitusb, n (percent) 3 (6.12%) 2 (2.27%) 0.35c
Hypercholesterolemiab, n (percent) 0 (0.0%) 0 (0.0%) n/a
Coronary artery diseaseb, n (percent) 0 (0.0%) 0 (0.0%) n/a
Smoking currently, n (percent) 2 (4.08%) 8 (9.09%) 0.49c
Body mass index, kg/m2, mean (SD) 23.29 (8.23) 21.14 (4.54) 0.054

aChi-square test for categorical variables and t-test for continuous variables, unless otherwise noted. bDocumented in medical records and/or self-reported by study participant. cFisher exact test used if one cell < 5. dMann–Whitney U test used for non-normally distributed data: interquartile range (IQR) reported instead of SD and median reported instead of mean. eStatistics for lesion count and volume calculated using only participants with 1 or more SCI. CaO2, arterial oxygen content; SaO2, blood oxygen saturation; SCD, sickle cell disease; SCI, silent cerebral infarct; HbSB0, hemoglobin S β0 thalassemia.